Microporous polyphenylenes with tunable pore size for hydrogen storage S Yuan, B Dorney, D White, S Kirklin, P Zapol, L Yu, DJ Liu Chemical communications 46 (25), 4547-4549, 2010 | 232 | 2010 |
Genotype–phenotype associations and human eye color D White, M Rabago-Smith Journal of human genetics 56 (1), 5-7, 2011 | 158 | 2011 |
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results CD Palmer, AR Rappaport, MJ Davis, MG Hart, CD Scallan, SJ Hong, ... Nature medicine 28 (8), 1619-1629, 2022 | 120 | 2022 |
Nanomedicine strategies for treatment of secondary spinal cord injury D White-Schenk, R Shi, JF Leary International journal of nanomedicine, 923-938, 2015 | 34 | 2015 |
Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2 D Schenk, G Song, Y Ke, Z Wang PLoS One 12 (7), e0181062, 2017 | 33 | 2017 |
Design and assessment of a wrapped cylindrical Ca‐P AZ31 Mg alloy for critical‐size ulna defect repair MR Smith, P Atkinson, D White, T Piersma, G Gutierrez, G Rossini, ... Journal of Biomedical Materials Research Part B: Applied Biomaterials 100 (1 …, 2012 | 33 | 2012 |
Porous organic polymers containing carborane for hydrogen storage S Yuan, D White, A Mason, DJ Liu International journal of energy research 37 (7), 732-740, 2013 | 32 | 2013 |
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results AR Rappaport, C Kyi, M Lane, MG Hart, ML Johnson, BS Henick, CY Liao, ... Nature Medicine 30 (4), 1013-1022, 2024 | 19 | 2024 |
Improving hydrogen adsorption enthalpy through coordinatively unsaturated cobalt in porous polymers S Yuan, D White, A Mason, B Reprogle, MS Ferrandon, L Yu, DJ Liu Macromolecular rapid communications 33 (5), 407-413, 2012 | 18 | 2012 |
Kinetics and mechanistic studies on the reaction between cytochrome c and tea catechins L Wang, E Santos, D Schenk, M Rabago-Smith Antioxidants 3 (3), 559-568, 2014 | 15 | 2014 |
Personalized viral-based prime/boost immunotherapy targeting patient-specific or shared neoantigens: Immunogenicity, safety, and efficacy results from two ongoing phase I studies. CG Drake, ML Johnson, AI Spira, GA Manji, DP Carbone, BS Henick, ... Journal of Clinical Oncology 38 (15_suppl), 3137-3137, 2020 | 10 | 2020 |
960MO Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC DV Catenacci, CY Liao, S Maron, BJ Solomon, A Mahipal, ML Johnson, ... Annals of Oncology 32, S830-S831, 2021 | 7 | 2021 |
736Mo personalized, off-the-shelf KRAS Neoantigen-specific Immunotherapy for the treatment of advanced solid tumors: clinical benefit associated with decreases in ctDNA (SLATE … CK Kyi, A Spira, DP Carbone, ML Johnson, BS Henick, B Johnson, ... Annals of Oncology 33, S880, 2022 | 6 | 2022 |
Mesoporous silica nanoparticles for treating spinal cord injury D White-Schenk, R Shi, JF Leary Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XI …, 2013 | 5 | 2013 |
659 COM701 plus nivolumab demonstrates preliminary antitumor activity and immune modulation of tumor microenvironment in patients with metastatic MSS-CRC and liver metastases D Rasco, E Dumbrava, M Sharma, D Shepard, D Vaena, G Fleming, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
Target capture and barcoding in monodisperse droplets R Meltzer, K Fontanez, D Schenk, Y Xue US Patent App. 17/281,157, 2021 | 3 | 2021 |
Hairpin primer design for sequential pcr production of targeted sequencing libraries R Meltzer, K Fontanez, D Schenk US Patent App. 16/998,685, 2021 | 2 | 2021 |
Mediating the potent ROS toxicity of acrolein in neurons involved in secondary spinal cord injury with silica nanoparticles and a natural product approach D White-Schenk, R Shi, JF Leary 89560C-89560C–11, 2014 | 2 | 2014 |
Cell-free dna monitoring JX Sun, MJ Davis, D Schenk, DN Gomez US Patent App. 17/861,088, 2023 | | 2023 |
Disease monitoring with comprehensive genomics provides evidence of mechanism of action and immune evasion in patients receiving an individualized neoantigen cancer vaccine D Schenk, R Zhou, O Petrillo, A Mantilla, IF do Valle, S Maron, BS Henick, ... Cancer Research 83 (7_Supplement), 1126-1126, 2023 | | 2023 |